Staff Reports
A new swirl of accusations has landed squarely on the doorstep of the National Institutes of Health. Independent journalist Laura Loomer reports that HHS Secretary Robert F. Kennedy Jr. personally confirmed a referral to the FBI tied to a whistleblower letter. The letter, published by the watchdog group White Coat Waste, alleges a coverup at Rocky Mountain Laboratories after a monkey bite and an alleged scheme to smuggle dangerous virus samples into the United States. This is explosive if true — and worth demanding answers for even if it is not yet proven.
What the recent reporting says
The story being passed around claims that NIH researcher Vincent Munster, Ph.D., was removed from directories and placed on leave after an internal whistleblower letter accused him and colleagues of trying to sneak viral hemorrhagic fever samples into the country. The same letter alleges a monkey bite exposed a staffer to Crimean‑Congo hemorrhagic fever and that RML went into “full coverup mode.” Laura Loomer says HHS Secretary Robert F. Kennedy Jr. told her the department referred the researcher to the FBI and added the dramatic line, “I assume he is going to prison.” Those are the claims. They deserve immediate scrutiny.
What is verified — and what is not
Certain facts are clear: White Coat Waste published the whistleblower letter and NIH’s Rocky Mountain Laboratories is a real high‑containment research site that works with dangerous pathogens. Vincent Munster is indeed an NIH scientist who studies viruses. What is not yet verified by mainstream or official channels is the dramatic confirmation attributed to HHS Secretary Kennedy and any public FBI investigation or criminal charges. No HHS press release or FBI announcement has appeared on the usual official pages to corroborate the Loomer quote or an open prosecution. In other words, the claims are serious and newsworthy, but the most explosive lines remain unconfirmed.
Why this matters: public safety and public trust
If there was an exposure to a viral hemorrhagic fever at an NIH lab, the public has a right to know how it happened and what was done to stop any risk. Even more so, if samples were moved from another country without proper documentation, that could violate select‑agent rules and national security protocols. Beyond the biosafety danger, there is a deeper problem: secrecy and a culture of protecting insiders. Americans pay for these labs. They deserve transparency instead of coverups and whisper campaigns that only land on partisan websites.
What must happen next
HHS and NIH should put the Loomer quote to rest one way or the other and publish clear statements about any referrals, suspensions, Form‑3 filings, or FBI contacts. The FBI and the Department of Justice should say if they have an active criminal probe. Congress should demand documents and hold hearings if answers are not forthcoming. And editors at mainstream outlets should stop treating this as gossip and do basic reporting: obtain the whistleblower letter, ask officials for comment, and force real answers. Americans do not get to shrink from scary facts — they get to demand accountability. If a coverup happened, prosecute it. If it did not, clear the record. Either way, transparency wins.
